Trials / Not Yet Recruiting
Not Yet RecruitingNCT07530497
Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- SI-BONE, Inc. · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate outcomes in patients treated with iFuse TORQ TNT for pelvic fragility fractures.
Detailed description
REBAR is a prospective, multicenter, single arm, post-market observational study conducted in a real-world setting on the usage of iFuse TORQ TNT.
Conditions
- Fracture; Pelvic
- Insufficiency Fractures
- Fragility Fracture
- Sacroiliac; Fusion
- Sacroiliac Joint Disruption
- Sacroiliac Joint Dysfunction
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iFuse TORQ TNT Implant System | FDA-clear implant used for fracture fixation of the pelvis, including acute, non-acute, and non-traumatic fractures and sacroiliac joint fusion for sacroiliac joint dysfunction including sacroiliac joint disruption and degenerative sacroiliitis. |
Timeline
- Start date
- 2026-08-01
- Primary completion
- 2028-02-01
- Completion
- 2028-08-01
- First posted
- 2026-04-15
- Last updated
- 2026-04-15
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07530497. Inclusion in this directory is not an endorsement.